Rulide

Roxithromycin Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.

Molecular Formula: C₄₁H₇₆N₂O₁₅

InChI: InChI=1/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23u,24+,25+,26-,27u,28?,29-,30?,32?,33+,34-,35?,36-,38?,39-,40u,41-/m1/s1

InChIKey: InChIKey=RXZBMPWDPOLZGW-AGOXYXIZBW
SMILES: CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O

Names:
    BRN 4286925
    CCRIS 3461
    Roxithromycine [French]
    Roxithromycinum [Latin]
    Roxithromycin [USAN:INN:JAN]
    roxithromycin
    Roxitromicina [Spanish]
    Rulide
    RU 28965
    RU 965
    (3R,4S,5R,6R,7R,9R,10E,11R,12R,13S,14R)-6-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one

Registries:
    PubChem CID 9567573
    PubChem ID 192099